258 related articles for article (PubMed ID: 27687955)
1. The thiirane-based selective MT1-MMP/MMP2 inhibitor ND-322 reduces melanoma tumor growth and delays metastatic dissemination.
Marusak C; Bayles I; Ma J; Gooyit M; Gao M; Chang M; Bedogni B
Pharmacol Res; 2016 Nov; 113(Pt A):515-520. PubMed ID: 27687955
[TBL] [Abstract][Full Text] [Related]
2. MT1-MMP modulates melanoma cell dissemination and metastasis through activation of MMP2 and RAC1.
Shaverdashvili K; Wong P; Ma J; Zhang K; Osman I; Bedogni B
Pigment Cell Melanoma Res; 2014 Mar; 27(2):287-96. PubMed ID: 24387669
[TBL] [Abstract][Full Text] [Related]
3. Selective function-blocking monoclonal human antibody highlights the important role of membrane type-1 matrix metalloproteinase (MT1-MMP) in metastasis.
Remacle AG; Cieplak P; Nam DH; Shiryaev SA; Ge X; Strongin AY
Oncotarget; 2017 Jan; 8(2):2781-2799. PubMed ID: 27835863
[TBL] [Abstract][Full Text] [Related]
4. BST-2 binding with cellular MT1-MMP blocks cell growth and migration via decreasing MMP2 activity.
Gu G; Zhao D; Yin Z; Liu P
J Cell Biochem; 2012 Mar; 113(3):1013-21. PubMed ID: 22065321
[TBL] [Abstract][Full Text] [Related]
5. MT1-MMP dependent repression of the tumor suppressor SPRY4 contributes to MT1-MMP driven melanoma cell motility.
Shaverdashvili K; Zhang K; Osman I; Honda K; Jobava R; Bedogni B
Oncotarget; 2015 Oct; 6(32):33512-22. PubMed ID: 26392417
[TBL] [Abstract][Full Text] [Related]
6. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
7. Targeting Extracellular Matrix Remodeling Restores BRAF Inhibitor Sensitivity in BRAFi-resistant Melanoma.
Marusak C; Thakur V; Li Y; Freitas JT; Zmina PM; Thakur VS; Chang M; Gao M; Tan J; Xiao M; Lu Y; Mills GB; Flaherty K; Frederick DT; Miao B; Sullivan RJ; Moll T; Boland GM; Herlyn M; Zhang G; Bedogni B
Clin Cancer Res; 2020 Nov; 26(22):6039-6050. PubMed ID: 32820016
[TBL] [Abstract][Full Text] [Related]
8. The membrane tethered matrix metalloproteinase MT1-MMP at the forefront of melanoma cell invasion and metastasis.
Thakur V; Bedogni B
Pharmacol Res; 2016 Sep; 111():17-22. PubMed ID: 27221755
[TBL] [Abstract][Full Text] [Related]
9. The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs.
Bartolomé RA; Ferreiro S; Miquilena-Colina ME; Martínez-Prats L; Soto-Montenegro ML; García-Bernal D; Vaquero JJ; Agami R; Delgado R; Desco M; Sánchez-Mateos P; Teixidó J
Am J Pathol; 2009 Feb; 174(2):602-12. PubMed ID: 19147814
[TBL] [Abstract][Full Text] [Related]
10. Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth.
Iida J; Wilhelmson KL; Price MA; Wilson CM; Pei D; Furcht LT; McCarthy JB
J Invest Dermatol; 2004 Jan; 122(1):167-76. PubMed ID: 14962105
[TBL] [Abstract][Full Text] [Related]
11. Role for furin in tumor necrosis factor alpha-induced activation of the matrix metalloproteinase/sphingolipid mitogenic pathway.
Tellier E; Nègre-Salvayre A; Bocquet B; Itohara S; Hannun YA; Salvayre R; Augé N
Mol Cell Biol; 2007 Apr; 27(8):2997-3007. PubMed ID: 17283058
[TBL] [Abstract][Full Text] [Related]
12. Synthesis of chiral ND-322, ND-364 and ND-364 derivatives as selective inhibitors of human gelatinase.
Yan Y; Chen X; Yang X; Zhang J; Xu W; Zhang Y
Bioorg Med Chem; 2015 Oct; 23(20):6632-40. PubMed ID: 26386821
[TBL] [Abstract][Full Text] [Related]
13. In vivo migration of transplanted myoblasts requires matrix metalloproteinase activity.
El Fahime E; Torrente Y; Caron NJ; Bresolin MD; Tremblay JP
Exp Cell Res; 2000 Aug; 258(2):279-87. PubMed ID: 10896779
[TBL] [Abstract][Full Text] [Related]
14. Activated leukocyte cell adhesion molecule (ALCAM/CD166/MEMD), a novel actor in invasive growth, controls matrix metalloproteinase activity.
Lunter PC; van Kilsdonk JW; van Beek H; Cornelissen IM; Bergers M; Willems PH; van Muijen GN; Swart GW
Cancer Res; 2005 Oct; 65(19):8801-8. PubMed ID: 16204050
[TBL] [Abstract][Full Text] [Related]
15. Ensnaring membrane type 1-matrix metalloproteinase (MT1-MMP) with tissue inhibitor of metalloproteinase (TIMP)-2 using the haemopexin domain of the protease as a carrier: a targeted approach in cancer inhibition.
Jiang B; Zhang Y; Liu J; Tsigkou A; Rapti M; Lee MH
Oncotarget; 2017 Apr; 8(14):22685-22699. PubMed ID: 28186971
[TBL] [Abstract][Full Text] [Related]
16. LIM kinase1 modulates function of membrane type matrix metalloproteinase 1: implication in invasion of prostate cancer cells.
Tapia T; Ottman R; Chakrabarti R
Mol Cancer; 2011 Jan; 10():6. PubMed ID: 21219645
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of Akt and FAK phosphorylation reduces invasion of glioblastoma cells by impairment of MT1-MMP shuttling to lamellipodia and downregulates MMPs expression.
Kwiatkowska A; Kijewska M; Lipko M; Hibner U; Kaminska B
Biochim Biophys Acta; 2011 May; 1813(5):655-67. PubMed ID: 21276823
[TBL] [Abstract][Full Text] [Related]
18. NHE1 mediates migration and invasion of HeLa cells via regulating the expression and localization of MT1-MMP.
Lin Y; Wang J; Jin W; Wang L; Li H; Ma L; Li Q; Pang T
Cell Biochem Funct; 2012 Jan; 30(1):41-6. PubMed ID: 21997166
[TBL] [Abstract][Full Text] [Related]
19. Cancer cell-associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors.
Perentes JY; Kirkpatrick ND; Nagano S; Smith EY; Shaver CM; Sgroi D; Garkavtsev I; Munn LL; Jain RK; Boucher Y
Cancer Res; 2011 Jul; 71(13):4527-38. PubMed ID: 21571860
[TBL] [Abstract][Full Text] [Related]
20. Targeting a Designer TIMP-1 to the Cell Surface for Effective MT1-MMP Inhibition: A Potential Role for the Prion Protein in Renal Carcinoma Therapy.
Jiang B; Liu J; Lee MH
Molecules; 2019 Jan; 24(2):. PubMed ID: 30641935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
